Role of Pyruvate Dehydrogenase Kinase 4 in Regulation of Blood Glucose Levels

다국어 초록 (Multilingual Abstract)

In the well-fed state a relatively high activity of the pyruvate dehydrogenase complex (PDC) reduces blood glucose levels by directing the carbon of pyruvate into the citric acid cycle. In the fasted state a relatively low activity of the PDC helps maintain blood glucose levels by conserving pyruvate and other three carbon compounds for gluconeogenesis. The relative activities of the pyruvate dehydrogenase kinases (PDKs) and the opposing pyruvate dehydrogenase phosphatases determine the activity of PDC in the fed and fasted states. Up regulation of PDK4 is largely responsible for inactivation of PDC in the fasted state. PDK4 knockout mice have lower fasting blood glucose levels than wild type mice, proving that up regulation of PDK4 is important for normal glucose homeostasis. In type 2 diabetes, up regulation of PDK4 also inactivates PDC, which promotes gluconeogenesis and thereby contributes to the hyperglycemia characteristic of this disease. When fed a high fat diet, wild type mice develop fasting hyperglycemia but PDK4 knockout mice remain euglycemic, proving that up regulation of PDK4 contributes to hyperglycemia in diabetes.
These finding suggest PDK4 inhibitors might prove useful in the treatment of type 2 diabetes.

참고문헌 (Reference)

1 Wellen KE, "nflammation, stress, and diabetes" 115 : 1111-1119, 2005

2 Rossmeisl M, "Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity" 52 : 1958-1966, 2003

3 Aicher TD, "Triterpene and diterpene inhibitors of pyruvate dehydrogenase kinase (PDK)" 9 : 2223-2228, 1999

4 Stacpoole PW, "The pharmacology of dichloroacetate" 38 : 1124-1144, 1989

5 Crabb DW, "The metabolic effects of dichloroacetate" 30 : 1024-1039, 1981

6 Holness MJ, "Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slowtwitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding" 49 : 775-781, 2000

7 Wu P, "Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues" 381 : 1-7, 2000

8 Wu P, "Star- vation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart" 329 : 197-201, 1998

9 Jeoung NH, "Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvation" 397 : 417-425, 2006

10 Sugden MC, "Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding" 395 : 246-252, 2001

11 You M, "Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice" 42 : 568-577, 2005

12 Savage DB, "Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2" 116 : 817-824, 2006

13 Behal RH, "Regulation of the pyruvate dehydrogenase multienzyme complex" 13 : 497-520, 1993

14 Patel MS, "Regulation of the pyruvate dehydrogenase complex" 34 : 217-222, 2006

15 Huang B, "Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator- activated receptor-alpha ligands, glucocorticoids, and insulin" 51 : 276-283, 2002

16 Rosa G, "Reduced PDK4 expression associates with increased insulin sensitivity in postobese patients" 11 : 176-182, 2003

17 Korotchkina LG, "R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase" 38 : 1083-1092, 2004

18 Jeoung NH, "Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice" 295 : 46-54, 2008

19 Hwang B, "Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet" 423 : 234-252, 2009

20 Cadoudal T, "Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue" 57 : 2272-2279, 2008

21 Spriet LL, "Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting" 96 : 2082-2087, 2004

22 Crunkhorn S, "Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation" 282 : 15439-15450, 2007

23 Leone TC, "PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis" 3 : 101-, 2005

24 Mayers RM, "PDH kinase inhibitors: a novel therapy for Type II diabetes" 33 (33): 367-370, 2005

25 Hakimi P, "Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse" 282 : 32844-32855, 2007

26 Jacob S, "Oral administration of RAC-alpha- lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial" 27 : 309-314, 1999

27 Peters SJ, "Muscle fiber type comparison of PDH kinase activity and isoform expression in fed and fasted rats" 280 : 661-668, 2001

28 Vendemiale G, "Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status" 33 : 808-815, 2001

29 Koves TR, "Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance" 7 : 45-56, 2008

30 Wu Z, "Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1" 98 : 115-124, 1999

31 Wu P, "Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes" 48 : 1593-1599, 1999

32 Baker JC, "Marked differences between two isoforms of human pyruvate dehydrogenase kinase" 275 : 15773-15781, 2000

33 Ravindran S, "Lipoyl domainbased mechanism for the integrated feedback control of the pyruvate dehydrogenase complex by enhancement of pyruvate dehydrogenase kinase activity" 271 : 653-662, 1996

34 Huang B, "Isoenzymes of pyruvate dehydrogenase phosphatase. DNAderived amino acid sequences, expression, and regulation" 273 : 17680-17688, 1998

35 Majer M, "Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects" 65 : 181-186, 1998

36 Blumenthal SA, "Inhibition of gluconeogenesis in rat liver by lipoic acid. Evidence for more than one site of action" 219 : 773-780, 1984

37 Lu CW, "Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance" 283 : 28106-28114, 2008

38 Chokkalingam K, "High-fat/low-carbohydrate diet reduces insulin-stimulated carbohydrate oxidation but stimulates nonoxidative glucose disposal in humans: An important role for skeletal muscle pyruvate dehydrogenase kinase 4" 92 : 284-292, 2007

39 Kim JW, "HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia" 3 : 177-185, 2006

40 Papandreou I, "HIF- 1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption" 3 : 187-197, 2006

41 Reshef L, "Glyceroneogenesis and the triglyceride/ fatty acid cycle" 278 : 30413-30416, 2003

42 Watt MJ, "Fluxing the mitochondria to insulin resistance" 7 : 5-6, 2008

43 Sugden MC, "Fibre-type specific modification of the activity and regulation of skeletal muscle pyruvate dehydrogenase kinase (PDK) by prolonged starvation and refeeding is associated with targeted regulation of PDK isoenzyme 4 expression" 346 : 651-657, 2000

44 Bowker-Kinley MM, "Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex" 329 : 191-196, 1998

45 Kalhan SC, "Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans" 57 : 305-312, 2008

46 Walgren JL, "Effect of R(+)alpha-lipoic acid on pyruvate metabolism and fatty acid oxidation in rat hepatocytes" 53 : 165-173, 2004

47 Bajotto G, "Downregulation of the skeletal muscle pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima Fatty rat both before and after the onset of diabetes mellitus" 75 : 2117-2130, 2004

48 Abbot EL, "Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells" 272 : 3004-3014, 2005

49 Kato M, "Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol" 15 : 992-1004, 2007

50 Clark AS, "Dichloroacetate inhibits glycolysis and augments insulin-stimulated glycogen synthesis in rat muscle" 79 : 588-594, 1987

51 Yount EA, "Comparison of the metabolic and toxic effects of 2-chloropropionate and dichloroacetate" 222 : 501-508, 1982

52 Burgess SC, "Carbohydrate-response element- binding protein deletion alters substrate utilization producing an energy-deficient liver" 283 : 1670-1678, 2008

53 Bebernitz GR, "Anilides of (R)-trifluoro- 2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase" 43 : 2248-2257, 2000

54 Lee WJ, "Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase" 25 : 2488-2494, 2005

55 Konrad T, "Alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes" 22 : 280-287, 1999

56 Franckhauser S, "Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity" 55 : 273-280, 2006

57 Morrell JA, "AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2" 31 (31): 1168-1170, 2003

58 Harris RA, "A new family of protein kinases: the mitochondrial protein kinases" 35 : 147-162, 1995

59 Olswang Y, "A mutation in the peroxisome proliferator-activated receptor gamma-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice" 99 : 625-630, 2002

60 Taggart AK, "(D)-beta- Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G" 280 : 26649-26652, 2005